Cognition Therapeutics(CGTX) - 2023 Q4 - Annual Report

| --- | --- | --- | |------------------------------------------------------|---------------------|-----------------------------------------------------| | Title of Each Class | Trading Symbol(s) | Name Of Each Exchange On Which Registered | | Common Stock, par value $0.001 per share | CGTX | The Nasdaq Stock Market LLC | SECURITIES AND EXCHANGE COMMISSION ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT ...